Biochemical markers, a tool for the aneuploidy diagnosis

2017, Number 1

Correo Científico Médico 2017; 21 (1)

Rodríguez PD, Robles GLM, Sánchez RE

Language: Spanish
References: 4
Page: 273-276
PDF size: 250.67 Kb.

Text Extraction

No abstract.

REFERENCES

Driscoll DA, Gross S. Prenatal Screening for Aneuploidy. N Engl J Med. 2009. [citado 22 nov 2015];360(24):2556-2562. Disponible en: http://www.nejm.org/doi/full/10.1056/NEJMcp0900134
Nicolaides KH. Screening for fetal a neuploidies at 11 to 13 weeks. Prenat Diagn. 2011. [citado 22 nov 2015]; 31 (1):7-15. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/pd.2637/full
Engelbrechtsen L, Brondum-Nielsen K, Ekelund C, Tabor A, Skibsted L. Detection of triploidy at 11-14 weeks of gestation: a cohort study of 198,000 pregnant women. Ultrasound Obstet Gynecol. 2013 [citado 22 nov 2015]; 42(5).530-535. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/uog.12460/full
Martínez Ruiz A, Vílchez JA, Sarabia Meseguer MD, López Expósito I, Cañizares Hernández F, Martínez Hernández P, et al. Performance evaluation of biochemical and ultrasound markers for the screening of chromosomal numerical abnormalities in the first trimester of pregnancy. Clin Lab. 2013 [citado 22 nov 2015]; 59(1-2):45-50. Disponible en: http://www.clin-lab-publications.com/article/1045